annual EBITDA:
-$108.04M+$379.35M(+77.83%)Summary
- As of today (May 21, 2025), NVAX annual EBITDA is -$108.04 million, with the most recent change of +$379.35 million (+77.83%) on December 31, 2024.
- During the last 3 years, NVAX annual EBITDA has risen by +$1.57 billion (+93.57%).
- NVAX annual EBITDA is now -4175.58% below its all-time high of -$2.53 million, reached on December 31, 2005.
Performance
NVAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$533.91M+$587.39M(+1098.35%)Summary
- As of today (May 21, 2025), NVAX quarterly EBITDA is $533.91 million, with the most recent change of +$587.39 million (+1098.35%) on March 31, 2025.
- Over the past year, NVAX quarterly EBITDA has increased by +$662.94 million (+513.79%).
- NVAX quarterly EBITDA is now at all-time high.
Performance
NVAX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$554.89M+$662.94M(+613.58%)Summary
- As of today (May 21, 2025), NVAX TTM EBITDA is $554.89 million, with the most recent change of +$662.94 million (+613.58%) on March 31, 2025.
- Over the past year, NVAX TTM EBITDA has increased by +$891.95 million (+264.63%).
- NVAX TTM EBITDA is now at all-time high.
Performance
NVAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +77.8% | +513.8% | +264.6% |
| 3 y3 years | +93.6% | +145.2% | +144.4% |
| 5 y5 years | +5.9% | +2538.8% | +663.4% |
NVAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.6% | at high | +207.6% | at high | +139.5% |
| 5 y | 5-year | at high | +93.6% | at high | +165.0% | at high | +133.0% |
| alltime | all time | -4175.6% | +93.6% | at high | +165.0% | at high | +133.0% |
NVAX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $533.91M(-1098.4%) | $554.89M(-613.6%) |
| Dec 2024 | -$108.04M(-77.8%) | -$53.48M(-49.3%) | -$108.04M(-50.1%) |
| Sep 2024 | - | -$105.40M(-158.6%) | -$216.35M(-5.2%) |
| Jun 2024 | - | $179.86M(-239.4%) | -$228.25M(-32.3%) |
| Mar 2024 | - | -$129.03M(-20.2%) | -$337.06M(-30.8%) |
| Dec 2023 | -$487.39M(-19.4%) | -$161.79M(+37.9%) | -$487.39M(-2.2%) |
| Sep 2023 | - | -$117.29M(-265.1%) | -$498.29M(-6.8%) |
| Jun 2023 | - | $71.06M(-125.4%) | -$534.62M(-51.5%) |
| Mar 2023 | - | -$279.36M(+61.8%) | -$1.10B(+82.2%) |
| Dec 2022 | -$604.71M(-64.0%) | -$172.69M(+12.4%) | -$604.71M(-51.7%) |
| Sep 2022 | - | -$153.63M(-69.0%) | -$1.25B(-10.9%) |
| Jun 2022 | - | -$496.11M(-327.9%) | -$1.41B(+12.5%) |
| Mar 2022 | - | $217.71M(-126.5%) | -$1.25B(-25.6%) |
| Dec 2021 | -$1.68B(+322.1%) | -$820.87M(+167.4%) | -$1.68B(+62.9%) |
| Sep 2021 | - | -$306.95M(-9.8%) | -$1.03B(+12.6%) |
| Jun 2021 | - | -$340.39M(+59.9%) | -$916.85M(+55.4%) |
| Mar 2021 | - | -$212.90M(+23.9%) | -$589.95M(+47.9%) |
| Dec 2020 | -$398.23M(+246.8%) | -$171.89M(-10.3%) | -$398.94M(+56.5%) |
| Sep 2020 | - | -$191.66M(+1320.4%) | -$254.90M(+229.5%) |
| Jun 2020 | - | -$13.49M(-38.4%) | -$77.35M(-21.5%) |
| Mar 2020 | - | -$21.89M(-21.4%) | -$98.49M(-14.2%) |
| Dec 2019 | -$114.83M(-30.2%) | -$27.85M(+97.3%) | -$114.83M(-12.5%) |
| Sep 2019 | - | -$14.12M(-59.2%) | -$131.28M(-16.2%) |
| Jun 2019 | - | -$34.63M(-9.4%) | -$156.65M(-2.9%) |
| Mar 2019 | - | -$38.23M(-13.7%) | -$161.41M(-1.8%) |
| Dec 2018 | -$164.40M(+2.8%) | -$44.30M(+12.2%) | -$164.40M(-0.5%) |
| Sep 2018 | - | -$39.48M(+0.2%) | -$165.29M(+1.2%) |
| Jun 2018 | - | -$39.39M(-4.5%) | -$163.37M(+0.3%) |
| Mar 2018 | - | -$41.23M(-8.8%) | -$162.88M(+1.9%) |
| Dec 2017 | -$159.88M(-38.1%) | -$45.20M(+20.3%) | -$159.88M(-3.7%) |
| Sep 2017 | - | -$37.56M(-3.4%) | -$166.06M(-12.1%) |
| Jun 2017 | - | -$38.89M(+1.7%) | -$189.03M(-15.6%) |
| Mar 2017 | - | -$38.23M(-25.6%) | -$223.86M(-13.4%) |
| Dec 2016 | -$258.50M(+71.5%) | -$51.38M(-15.1%) | -$258.50M(-9.0%) |
| Sep 2016 | - | -$60.52M(-17.9%) | -$284.17M(+11.4%) |
| Jun 2016 | - | -$73.73M(+1.2%) | -$255.15M(+27.2%) |
| Mar 2016 | - | -$72.87M(-5.4%) | -$200.56M(+33.1%) |
| Dec 2015 | -$150.71M(+92.3%) | -$77.06M(+144.6%) | -$150.71M(+45.2%) |
| Sep 2015 | - | -$31.50M(+64.7%) | -$103.77M(+14.1%) |
| Jun 2015 | - | -$19.13M(-16.9%) | -$90.91M(+2.6%) |
| Mar 2015 | - | -$23.02M(-23.5%) | -$88.61M(+13.1%) |
| Dec 2014 | -$78.37M(+59.3%) | -$30.11M(+61.5%) | -$78.37M(+27.8%) |
| Sep 2014 | - | -$18.64M(+10.7%) | -$61.32M(+7.1%) |
| Jun 2014 | - | -$16.84M(+31.8%) | -$57.24M(+9.1%) |
| Mar 2014 | - | -$12.78M(-2.2%) | -$52.48M(+6.6%) |
| Dec 2013 | -$49.21M(+83.5%) | -$13.07M(-10.3%) | -$49.21M(+12.6%) |
| Sep 2013 | - | -$14.56M(+20.6%) | -$43.70M(+21.6%) |
| Jun 2013 | - | -$12.07M(+27.0%) | -$35.95M(+22.3%) |
| Mar 2013 | - | -$9.51M(+25.7%) | -$29.39M(+9.6%) |
| Dec 2012 | -$26.81M(+54.7%) | -$7.57M(+11.2%) | -$26.81M(+19.0%) |
| Sep 2012 | - | -$6.80M(+23.5%) | -$22.53M(+21.6%) |
| Jun 2012 | - | -$5.51M(-20.5%) | -$18.53M(+7.7%) |
| Mar 2012 | - | -$6.93M(+110.9%) | -$17.20M(-0.8%) |
| Dec 2011 | -$17.33M(-50.2%) | -$3.29M(+17.3%) | -$17.33M(-14.5%) |
| Sep 2011 | - | -$2.80M(-33.0%) | -$20.26M(-26.2%) |
| Jun 2011 | - | -$4.18M(-40.8%) | -$27.45M(-13.6%) |
| Mar 2011 | - | -$7.06M(+13.6%) | -$31.79M(-11.4%) |
| Dec 2010 | -$34.78M | -$6.21M(-37.8%) | -$35.89M(-21.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$10.00M(+17.4%) | -$45.71M(+4.7%) |
| Jun 2010 | - | -$8.52M(-23.7%) | -$43.68M(+2.3%) |
| Mar 2010 | - | -$11.16M(-30.4%) | -$42.68M(+11.2%) |
| Dec 2009 | -$38.37M(+14.6%) | -$16.04M(+101.3%) | -$38.37M(+22.9%) |
| Sep 2009 | - | -$7.96M(+5.9%) | -$31.23M(-5.3%) |
| Jun 2009 | - | -$7.52M(+9.9%) | -$32.98M(-0.9%) |
| Mar 2009 | - | -$6.84M(-23.1%) | -$33.30M(-0.5%) |
| Dec 2008 | -$33.47M(+13.7%) | -$8.90M(-8.5%) | -$33.47M(+21.2%) |
| Sep 2008 | - | -$9.72M(+24.0%) | -$27.61M(+3.0%) |
| Jun 2008 | - | -$7.84M(+11.8%) | -$26.80M(-0.8%) |
| Mar 2008 | - | -$7.01M(+130.2%) | -$27.02M(-3.0%) |
| Dec 2007 | -$29.44M(+41.9%) | -$3.04M(-65.8%) | -$27.85M(-1.1%) |
| Sep 2007 | - | -$8.91M(+10.5%) | -$28.16M(+14.3%) |
| Jun 2007 | - | -$8.06M(+2.8%) | -$24.64M(+8.5%) |
| Mar 2007 | - | -$7.84M(+134.1%) | -$22.71M(+20.2%) |
| Dec 2006 | -$20.75M(+720.9%) | -$3.35M(-37.9%) | -$18.89M(+374.7%) |
| Sep 2006 | - | -$5.39M(-12.1%) | -$3.98M(-2807.5%) |
| Jun 2006 | - | -$6.13M(+52.6%) | $147.00K(-93.0%) |
| Mar 2006 | - | -$4.02M(-134.8%) | $2.09M(-263.6%) |
| Dec 2005 | -$2.53M(-88.2%) | $11.56M(-1015.5%) | -$1.28M(-94.1%) |
| Sep 2005 | - | -$1.26M(-69.8%) | -$21.86M(-1.1%) |
| Jun 2005 | - | -$4.19M(-43.3%) | -$22.11M(-9.9%) |
| Mar 2005 | - | -$7.39M(-18.1%) | -$24.55M(+14.7%) |
| Dec 2004 | -$21.41M(+44.0%) | -$9.02M(+496.5%) | -$21.41M(+41.4%) |
| Sep 2004 | - | -$1.51M(-77.2%) | -$15.14M(-7.0%) |
| Jun 2004 | - | -$6.63M(+56.1%) | -$16.28M(+16.3%) |
| Mar 2004 | - | -$4.25M(+54.6%) | -$13.99M(-5.9%) |
| Dec 2003 | -$14.87M(-27.2%) | -$2.75M(+3.7%) | -$14.87M(-6.7%) |
| Sep 2003 | - | -$2.65M(-39.1%) | -$15.93M(-18.2%) |
| Jun 2003 | - | -$4.35M(-15.1%) | -$19.48M(-4.4%) |
| Mar 2003 | - | -$5.12M(+34.4%) | -$20.36M(-0.3%) |
| Dec 2002 | -$20.42M(+254.1%) | -$3.81M(-38.5%) | -$20.42M(+8.9%) |
| Sep 2002 | - | -$6.20M(+18.4%) | -$18.75M(+33.3%) |
| Jun 2002 | - | -$5.24M(+1.1%) | -$14.06M(+46.9%) |
| Mar 2002 | - | -$5.18M(+142.3%) | -$9.58M(+66.1%) |
| Dec 2001 | -$5.77M(-52.5%) | -$2.14M(+41.2%) | -$5.77M(-31.6%) |
| Sep 2001 | - | -$1.51M(+102.5%) | -$8.43M(-17.3%) |
| Jun 2001 | - | -$747.00K(-45.4%) | -$10.19M(-16.2%) |
| Mar 2001 | - | -$1.37M(-71.5%) | -$12.16M(+0.1%) |
| Dec 2000 | -$12.15M(+189.2%) | -$4.80M(+46.6%) | -$12.15M(+45.5%) |
| Sep 2000 | - | -$3.27M(+20.2%) | -$8.35M(+25.1%) |
| Jun 2000 | - | -$2.72M(+101.3%) | -$6.68M(+40.5%) |
| Mar 2000 | - | -$1.35M(+35.3%) | -$4.75M(+13.2%) |
| Dec 1999 | -$4.20M(-14.3%) | -$1.00M(-37.5%) | -$4.20M(-12.5%) |
| Sep 1999 | - | -$1.60M(+100.0%) | -$4.80M(+9.1%) |
| Jun 1999 | - | -$800.00K(0.0%) | -$4.40M(-8.3%) |
| Mar 1999 | - | -$800.00K(-50.0%) | -$4.80M(0.0%) |
| Dec 1998 | -$4.90M(+8.9%) | -$1.60M(+33.3%) | -$4.80M(+14.3%) |
| Sep 1998 | - | -$1.20M(0.0%) | -$4.20M(+2.4%) |
| Jun 1998 | - | -$1.20M(+50.0%) | -$4.10M(-2.4%) |
| Mar 1998 | - | -$800.00K(-20.0%) | -$4.20M(-4.5%) |
| Dec 1997 | -$4.50M(-13.5%) | -$1.00M(-9.1%) | -$4.40M(-13.7%) |
| Sep 1997 | - | -$1.10M(-15.4%) | -$5.10M(+4.1%) |
| Jun 1997 | - | -$1.30M(+30.0%) | -$4.90M(+2.1%) |
| Mar 1997 | - | -$1.00M(-41.2%) | -$4.80M(0.0%) |
| Dec 1996 | -$5.20M | -$1.70M(+88.9%) | -$4.80M(+54.8%) |
| Sep 1996 | - | -$900.00K(-25.0%) | -$3.10M(+40.9%) |
| Jun 1996 | - | -$1.20M(+20.0%) | -$2.20M(+120.0%) |
| Mar 1996 | - | -$1.00M | -$1.00M |
FAQ
- What is Novavax annual EBITDA?
- What is the all time high annual EBITDA for Novavax?
- What is Novavax annual EBITDA year-on-year change?
- What is Novavax quarterly EBITDA?
- What is the all time high quarterly EBITDA for Novavax?
- What is Novavax quarterly EBITDA year-on-year change?
- What is Novavax TTM EBITDA?
- What is the all time high TTM EBITDA for Novavax?
- What is Novavax TTM EBITDA year-on-year change?
What is Novavax annual EBITDA?
The current annual EBITDA of NVAX is -$108.04M
What is the all time high annual EBITDA for Novavax?
Novavax all-time high annual EBITDA is -$2.53M
What is Novavax annual EBITDA year-on-year change?
Over the past year, NVAX annual EBITDA has changed by +$379.35M (+77.83%)
What is Novavax quarterly EBITDA?
The current quarterly EBITDA of NVAX is $533.91M
What is the all time high quarterly EBITDA for Novavax?
Novavax all-time high quarterly EBITDA is $533.91M
What is Novavax quarterly EBITDA year-on-year change?
Over the past year, NVAX quarterly EBITDA has changed by +$662.94M (+513.79%)
What is Novavax TTM EBITDA?
The current TTM EBITDA of NVAX is $554.89M
What is the all time high TTM EBITDA for Novavax?
Novavax all-time high TTM EBITDA is $554.89M
What is Novavax TTM EBITDA year-on-year change?
Over the past year, NVAX TTM EBITDA has changed by +$891.95M (+264.63%)